Related references
Note: Only part of the references are listed.A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes
Xiaolei Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells
Y. Gan et al.
ONCOGENE (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
Karuppaiyah Selvendiran et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts
Karuppaiyah Selvendiran et al.
CELL CYCLE (2008)
Epithelial-mesenchymal transition in cervical cancer: Correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation
Mei-Yi Lee et al.
CLINICAL CANCER RESEARCH (2008)
Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion
Bhavik Desai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects
Khandaker A. Z. Siddiquee et al.
ACS CHEMICAL BIOLOGY (2007)
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells
Mitsuhiro Matsuo et al.
CANCER LETTERS (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment
M. Villedieu et al.
GYNECOLOGIC ONCOLOGY (2006)
Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
T Gritsko et al.
CLINICAL CANCER RESEARCH (2006)
STAT3-mediated transcription of Bcl-2, Mcl-1 and c-lAP2 prevents apoptosis in polyamine-depleted cells
S Bhattacharya et al.
BIOCHEMICAL JOURNAL (2005)
Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of gefitinib in bladder cancer cells.
W Kassouf et al.
CANCER RESEARCH (2005)
Drug resistance in ovarian cancer: The emerging importance of gene transcription and spatio-temporal regulation of resistance
A Richardson et al.
DRUG RESISTANCE UPDATES (2005)
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
E Avizienyte et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells
YK Kim et al.
JOURNAL OF APPLIED TOXICOLOGY (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs
V Brabec et al.
DRUG RESISTANCE UPDATES (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
I Arany et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
STAT proteins as novel targets for cancer drug discovery
J Turkson
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Targeting epidermal growth factor receptor - are we missing the mark?
JE Dancey et al.
LANCET (2003)
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Y Aoki et al.
BLOOD (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
WM Burke et al.
ONCOGENE (2001)
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
PK Epling-Burnette et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Constitutive activation of Stat 3 oncogene product in human ovarian carcinoma cells
M Huang et al.
GYNECOLOGIC ONCOLOGY (2000)
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
